Home › Job titles › Regulatory and Compliance Analyst
Regulatory and Compliance Analyst: H-1B salaries
84 labor condition applications used the job title Regulatory and Compliance Analyst. Median offered base salary $76,294; middle half $66,622–$87,360.
Applications (LCAs)84
Median offered salary$76,294
Middle half of salaries$66,622–$87,360
10th–90th percentile$60,366–$104,000
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Ridgewood City Pharmacy | 4 | $86,668 |
| St. Jesus Pharmacy Corp | 3 | $75,681 |
| West 14 Pharmacy Corp. | 3 | $110,000 |
| Ny Drugs, Inc. | 2 | $81,438 |
| Jerry’s Drug & Surgical LLC | 2 | $75,629 |
| Riverside SRX Inc | 2 | $88,985 |
| Fitwel Pharmacy LLC | 2 | $75,629 |
| Jai Chamunda Morenci Inc. | 2 | $70,000 |
| Shanti Pharmacy Corp. | 2 | $78,114 |
| J. D. Pharmacy Inc. | 2 | $64,740 |
| Satya Soft Solutions LLC | 2 | $76,294 |
| Arrow Apothecary Corp | 2 | $67,746 |
| Healthy Society LLC | 2 | $51,896 |
| Prasanna LLC | 2 | $145,600 |
| Devaria LLC | 2 | — |
| Quality Pharmacy Corp | 2 | $59,434 |
| RCK Pharmacy LLC | 2 | $86,000 |
| Simpson Pharmacy Inc | 2 | $82,000 |
| Bridgeport Chemists, Inc. | 1 | $70,000 |
| Shivani Pharmacy Inc | 1 | $75,920 |
| Apollo Pharma Inc | 1 | — |
| White Globe LLC | 1 | $60,798 |
| SS Drugs Inc. | 1 | $75,629 |
| DB Medical Supplies Inc | 1 | — |
| Health First Pharmacy Corp. | 1 | $59,322 |
| Rainbow Care Pharma Inc. | 1 | — |
| EZ Care RX Inc | 1 | $90,480 |
| Shiv Hari RX Inc. | 1 | $76,960 |
| GCC Pharmacy Corp | 1 | $60,320 |
| Village Pharmacy Corp | 1 | $76,294 |
| Gateway Center Pharmacy LLC | 1 | $65,000 |
| Bcrr RX Inc. | 1 | $80,600 |
| Super Drugs RX LLC | 1 | $66,622 |
| Sai Chandi Pharmacy LLC | 1 | $110,000 |
| Myth Services Inc. | 1 | $124,800 |
| Community Health Pharmacy LLC | 1 | $84,000 |
| Hudson View Pharmacy, Inc. | 1 | $79,040 |
| Gspm Pharmacy Inc | 1 | $104,000 |
| ssanj rx inc | 1 | $90,000 |
| Regal Pharmacy LLC | 1 | $76,294 |
| KMN Pharmacy Corp | 1 | $91,000 |
| Shri Hari RX Corp. | 1 | $95,680 |
| Compare Quality Pharmacy | 1 | $62,000 |
| SAMP RX Inc. | 1 | $87,360 |
| Watervliet Community Pharmacy LLC | 1 | $70,000 |
| Truptisudhir Pharmacy Corp | 1 | $77,667 |
| RSP Pharmacy Corp | 1 | $68,000 |
| Forecastex LLC | 1 | $68,848 |
| Esquire Pharmacy Inc | 1 | $60,549 |
| Desai's Pharmacy Inc | 1 | $65,000 |
| Vishal Pharmacy Corp | 1 | $65,000 |
| Brookdale Pharma Inc. | 1 | $93,600 |
| Bridgeport Pharmacy LLC | 1 | $105,000 |
| SN Pharmacy LLC | 1 | $77,667 |
| Tompkinsville RX Inc | 1 | $84,448 |
| Apex Pharmacy | 1 | — |
| Tru Med Pharmacy Inc | 1 | $62,837 |
| Bansi Pharmacy Inc | 1 | — |
| 161 St Pharma RX Inc | 1 | $80,600 |
| Irvington Pharmacy LLC | 1 | $80,600 |
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $62,000 |
| Level II (qualified) | $78,529 |
| Level III (experienced) | $94,806 |
| Level IV (fully competent) | $112,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 18 | $71,880 |
| FY2024 | 23 | $76,960 |
| FY2025 | 20 | $77,667 |
| FY2026 | 12 | $81,300 |
Cities
- New York, NY21
- Bronx, NY15
- Brooklyn, NY5
- Ridgewood, NY4
- Worcester, MA3
- Bridgeport, CT2
- Bayonne, NJ2
- Lakewood Township, NJ2
- Morenci, MI2
- Rahway, NJ2
- Newark, NJ2
- Guttenberg, NJ2
- Livingston, NJ1
- Carrollton, TX1
- Framingham, MA1
- Flushing, NY1
- Nederland, TX1
- Mount Holly, NJ1
- Mountholly, NJ1
- Philadelphia, PA1
- Houston, TX1
- New Haven, CT1
- Newburgh, NY1
- Ewing, NJ1
- Watervliet, MI1
- New Canaan, CT1
- Chicago, IL1
- San Antonio, TX1
- Union City, NJ1
- Staten Island, NY1
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).